First Trust Indxx Medical Devices ETF Rating $21.67 +0.16 (+0.74%) As of 08/21/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings First Trust Indxx Medical Devices ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MDEV Aggregate RatingModerate Buy 2.59Holdings in MDEV have an aggregate rating of Moderate Buy based on 277 analyst ratings issued in the past year covering 16 companies (37.1% of the portfolio).MDEV Aggregate Price Target$21.67High Prediction$21.67Average Prediction$21.67Low Prediction$21.67Holdings in MDEV have an aggregate price target of $21.67 and a range of $21.67 to $21.67 covering 16 companies (37.1% of the portfolio).MDEV Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Indxx Medical Devices ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 16 MDEV Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.89%BAXBaxter International$26.37-0.2%1.7332 of 5 stars2.00$22.45 -14.8%13Analyst Revision2.60%DXCMDexCom$92.34+2.3%4.3213 of 5 stars2.89$88.71 -3.9%27Positive News2.51%WSTWest Pharmaceutical Services$352.94-0.2%3.9742 of 5 stars2.87$368.08 4.3%152.45%MMSIMerit Medical Systems$90.78+0.6%3.4372 of 5 stars2.67$100.00 10.2%12Analyst Upgrade2.41%RVTYRevvity$124.88+0.6%3.3477 of 5 stars2.20$108.36 -13.2%15Positive News2.38%WATWaters$412.37+1.9%2.8306 of 5 stars2.75$420.35 1.9%202.38%BIOBio-Rad Laboratories$381.56+1.4%1.8789 of 5 stars2.20$343.33 -10.0%5Gap Up2.37%AAgilent Technologies$159.25+1.9%4.5202 of 5 stars2.89$160.24 0.6%19News CoveragePositive NewsUpcoming Earnings2.36%LIVNLivaNova$78.74+0.7%2.8511 of 5 stars2.55$83.50 6.0%11Positive NewsAnalyst Upgrade2.21%TMOThermo Fisher Scientific$629.02+0.2%4.4911 of 5 stars2.78$619.41 -1.5%23News CoveragePositive NewsInsider Trade2.19%EWEdwards Lifesciences$89.89+0.1%4.3222 of 5 stars2.74$100.27 11.6%23Positive News2.18%BDXBecton, Dickinson and Company$191.95+2.3%3.5622 of 5 stars2.41$185.67 -3.3%17Positive News2.11%TFXTeleflex$138.99+3.0%3.9411 of 5 stars2.42$151.80 9.2%122.03%ABTAbbott Laboratories$116.62+2.2%4.4981 of 5 stars2.96$118.67 1.8%27Trending News2.01%MTDMettler-Toledo International$1,393.43+0.0%3.4667 of 5 stars2.46$1,461.27 4.9%13Positive NewsHigh Trading Volume1.99%DHRDanaher$219.42+1.6%4.0284 of 5 stars2.84$228.91 4.3%25News CoveragePositive News This page (BATS:MDEV) was last updated on 8/22/2026 by MarketBeat.com Staff. From Our PartnersThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredYour Free Report (Inside)A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | Sponsored23,281 stocks. Only ONE survived.One American energy producer just cleared a screen of 23281 stocks for elite operating profits, double-digit r...Monument Traders Alliance | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredSomeone just dumped the biggest gold fund.Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to...Behind the Markets | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Indxx Medical Devices ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Indxx Medical Devices ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.